BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...

The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

Please provide your email address to receive an email when new articles are posted on . Testing requires parvalbumins as well as raw and heated extracts from multiple fish species for the greatest ...

Allogene Therapeutics has announced an expanded collaboration with Foresight Diagnostics to develop a minimal residual disease (MRD) assay as a companion diagnostic tool for identifying patients with ...

Lucid's Q3 2025 showed 2,841 tests and $7.1 million in pro forma revenues billed, but only $1.2 million could be ...

Infectious disease expert Dr. Mark Kortepeter explains the pros and cons of at-home Covid diagnostic tests and how to interpret the results. One of the major challenges with having everyone receive ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 ...

A potential blood test can distinguish ME/chronic fatigue syndrome with great accuracy, after years of medical uncertainty.

8.2 Global Monkeypox Diagnostics Markets Overview by Assay 8.3 Global Monkeypox Diagnostics Markets Overview by Product 8.4 Global Monkeypox Diagnostics Markets Overview by Place ...